Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients
Background: Cholangiocarcinoma (CCA) is a diverse group of aggressive liver tumors with up to 20% being intrahepatic CCA (iCCA). Up to 15% of patients with iCCA have fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements. Here we evaluated iCCA treatment with pemigatinib, a selective...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Medical Journals Sweden
2025-04-01
|
| Цуврал: | Acta Oncologica |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://medicaljournalssweden.se/actaoncologica/article/view/42073 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|